Back the Next Generation
of Drug Delivery

Avicenna is building the technology to make injectable medication safer, more stable, and more accessible.

Become an Investor

Why Invest in Avicenna Therapeutic Technologies

Proprietary MIST™ Technology

A plunger-less, vacuum-sealed device that eliminates silicone oil, leachables, and air bubbles while supporting complex, viscous drugs.

Massive Market Opportunity

Targets a prefilled syringe market expanding from $26.85B to $59.39B by 2034, driven by rising demand for biologics and mRNA therapies.

Strong Financial Impact

Cuts pharma cold-chain costs by 30–60% and monetizes across four streams, including recurring cartridge sales ($1–$5/unit) and licensing.

Accelerating Growth

Projects $106.26M revenue by Year 5 with $45.52M net income; currently raising $1M via a SAFE note (20% discount, $10M cap).

Become an Investor

Why This Is A Breakthrough?

Extended Stability
Vacuum/inert-gas atmosphere dramatically slows drug degradation.
No Silicone Oil
Avoids a major cause of contamination, protein aggregation & E&L failures.
No Air Bubble → Zero Overfill
Reduced product wastage with significantly better dosing accuracy.
Cold Chain Reduction
Some vaccines & biologics may not need refrigerated transport and storage.
Works With Viscous Liquids & Gases
Unique transport advantages over regular mechanical syringes.
Plungerless = Zero Contact
Better purity → ideal for sensitive biologics, mRNA, and advanced therapies.
Interchangeable Actuators
Supports manual, pen injector, autoinjector, or smart micro-pump.

Invest in the Future of Drug Delivery

A system built to solve real problems in drug delivery, compliance, and cost.

$59.39B

Projected global syringes market by 2034

$35B+

Lost annually to injectable logistics failures worldwide

8.27%

Market CAGR, 2025–2034

30–60%

Reduction in cold-chain costs with MIST

Explore Investment

Our Team of Experts

Founded in 2026, Avicenna Therapeutic Tech, Inc., a DE C-corp. set out to solve a problem the industry had accepted: how to keep injectable medication stable and sterile without compromise.
‍
Our team draws on decades of experience across medical devices, pharma, biotech, and manufacturing to bring MIST from concept to reality.

Learn More

FAQ

What is MIST?
This is some text inside of a div block.
How does Avicenna's business model work?
This is some text inside of a div block.This is some text inside of a div block.This is some text inside of a div block.This is some text inside of a div block.This is some text inside of a div block.
What stage is the company at?
This is some text inside of a div block.

Interested in Learning More?

Get in touch to talk about partnership and investment opportunities.

Get in Touch

TechnologyInvestorsTeam
Contact

© 2026 Avicenna. All rights reserved.